Published in Aging and Elder Health Week, February 13th, 2005
The company intends to ship product to the U.S. and initiate enrollment of subjects before the end of January 2005. The Fluviral vaccine to be tested was produced using a terminal sterile filtration step.
This minor modification to the production process is an FDA requirement for flu vaccines entering the U.S. market. ID Biomedical also announced that it has completed enrollment of a similar clinical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Aging and Elder Health Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.